Treace Medical Concepts, Inc. TMCI
Set alert
4.43 USD -0.63 -12.45%
At close · Oct 30
4.43 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
4.36 Day range 5.07
1.20 52-week range 6.59
- YTD
- +80.82%
- 1 year
- -30.24%
- Open
- 5.06
- Prev close
- 5.06
- Mkt cap
- 288.10M
- Vol
- 290.60K
- Avg vol
- 283.95K
- EPS
- -0.92
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.36
- High
- 5.07
- Forward P/E
- -9.28
- Beta
- 0.24
- Short ratio
- 3.26
- Inst. own
- 64.11%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 6.87
- 200-d avg
- 7.45
- 1y target
- 7.96
2Y chart
Events in this range
- Nov 5, 2024Earnings: -0.25; estimate -0.27; surprise 7.41%
- Nov 6, 2024Rating: Stifel · Hold → Hold
- Dec 18, 2024Rating: Truist Securities · Hold → Hold
Signals (71)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 29, 2026 | 2 days ago |
| SMA: Bullish | Oct 26, 2026 | 5 days ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 3, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 2 months ago |
| MACD: Sell Signal | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| RSI: Overbought | Jun 23, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 22, 2026 | 4 months ago |
| RSI: Overbought | Jun 12, 2026 | 4 months ago |
| SMA: Bullish | Jun 9, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 4 months ago |
| RSI: Overbought | May 13, 2026 | 5 months ago |
| MACD: Buy Signal | May 12, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| RSI: Overbought | Apr 14, 2026 | 6 months ago |
| SMA: Bullish | Apr 10, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 17, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 3, 2026 | 8 months ago |
| RSI: Oversold | Mar 3, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| RSI: Oversold | Feb 12, 2026 | 8 months ago |
| RSI: Oversold | Feb 3, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 28, 2026 | 9 months ago |
| RSI: Oversold | Dec 16, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| RSI: Oversold | Nov 7, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 5, 2025 | 12 months ago |
| SMA: Bullish | Oct 24, 2025 | 1 year ago |
| SMA: Bullish | Oct 21, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 17, 2025 | 1 year ago |
| SMA: Bearish | Oct 1, 2025 | 1 year ago |
| SMA: Bearish | Sep 12, 2025 | 1 year ago |
| SMA: Bullish | Sep 11, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 3, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| RSI: Overbought | Aug 18, 2025 | 1 year ago |
| RSI: Overbought | Aug 13, 2025 | 1 year ago |
| SMA: Bullish | Aug 8, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 25, 2025 | 1 year ago |
| SMA: Bearish | Jul 24, 2025 | 1 year ago |
| SMA: Bullish | Jul 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 20, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 9, 2025 | 1 year ago |
| RSI: Oversold | May 23, 2025 | 1 year ago |
| MACD: Sell Signal | May 19, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 25, 2025 | 1 year ago |
| RSI: Oversold | Apr 11, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 4, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 24, 2025 | 1 year ago |
| SMA: Bearish | Mar 6, 2025 | 1 year ago |
| SMA: Bullish | Mar 5, 2025 | 1 year ago |
| SMA: Bearish | Mar 3, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 11, 2025 | 1 year ago |
| RSI: Overbought | Jan 29, 2025 | 1 year ago |
| RSI: Overbought | Jan 27, 2025 | 1 year ago |
| RSI: Overbought | Jan 22, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
Key statistics
- Market cap
- 433.59M
- Enterprise value
- 420.91M
- Trailing P/E
- 0.00
- Forward P/E
- -9.28
- PEG ratio
- 0.00
- Price / sales
- 2.14
- Price / book
- 4.13
- EPS (TTM)
- -0.99
- Beta
- 0.24
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -30.33%
- Revenue (TTM)
- 202.86M
- Revenue growth
- 10.60%
- Free cash flow
- -20.63M
- Total cash
- 82.80M
- Total debt
- 70.12M
- Return on equity
- -50.69%
- Shares outstanding
- 62.30M
- Short % of float
- 5.32%
- 50-day average
- 6.87
- 200-day average
- 7.45
Analyst view
Consensus: hold
Hold
Price target (mean) 7.96 +79.7% upside
Now 4.43
- Target (low)
- 7.50
- Target (mean)
- 7.96
- Target (high)
- 8.40
Ratings (0m) 6 0 buy · 6 hold · 0 sell
- Strong buy0
- Buy0
- Hold6
- Sell0
- Strong sell0
Next earnings
Aug 6, 2024
Expected Aug 6, 2024. Consensus EPS estimate -0.04032.
Financials — quick view
TMCI Revenue — quarterly 45.38M
TMCI Net income — quarterly -15.87M
TMCI EPS — quarterly -0.24
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2024 | Sep 1, 2024 | -0.27 | -0.25 | +0.02 | +7.41% |
| Aug 6, 2024 | Jun 1, 2024 | -0.29 | -0.34 | -0.05 | -17.24% |
| Aug 6, 2024 | Jun 1, 2024 | -0.29 | — | — | — |
| May 7, 2024 | Mar 1, 2024 | -0.30 | -0.30 | 0.00 | 0.00% |
| May 7, 2024 | Mar 1, 2024 | -0.30 | — | — | — |
| Feb 27, 2024 | Dec 1, 2023 | -0.09 | -0.10 | -0.01 | -11.11% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 18, 2024 | Truist Securities | main | Hold | Hold |
| Nov 6, 2024 | Stifel | main | Hold | Hold |
| Oct 14, 2024 | Truist Securities | main | Hold | Hold |
| Aug 7, 2024 | UBS | main | Neutral | Neutral |
| Aug 7, 2024 | Truist Securities | main | Hold | Hold |
| Jul 16, 2024 | Truist Securities | main | Hold | Hold |
About Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- treace.com
News
- Treace to Report Third Quarter 2026 Financial Results on November 6, 2026
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Treace Medical Presents 5-Year ALIGN3D Data Showing 0.8% Recurrence Rate Alongside MTA3D And SPRINT Clinical Results At AOFAS 2026
- Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
- Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting
- Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $5
- Treace Medical Concepts, Inc. (TMCI) Q2 2026 Earnings Call Transcript
- Treace Medical Concepts Q2 Earnings Call Highlights
Your note
Sign in to keep a note on TMCI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAKEWELL JOHN K | Director | Stock Award(Grant) | May 20, 2024 | 492,439 |
| BERRY LANCE A | Director | Stock Award(Grant) | May 20, 2024 | 20,676 |
| BERUTTI AARON | Officer | Stock Award(Grant) | Aug 8, 2024 | 165,791 |
| ELDER SCOT MICHAEL | Officer | Stock Award(Grant) | Nov 10, 2024 | 449,678 |
| HAIR MARK | Chief Financial Officer | Stock Award(Grant) | Aug 8, 2024 | 369,115 |
| HAMILTON LAWRENCE W | Director | Stock Award(Grant) | May 20, 2024 | 20,139 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.95% | 6,196,000 | 43.12M | Sep 29, 2024 |
| Blackrock Inc. | 6.71% | 4,182,320 | 29.11M | Sep 29, 2024 |
| Morgan Stanley | 5.26% | 3,274,057 | 22.79M | Sep 29, 2024 |
| Vanguard Group Inc | 4.40% | 2,741,488 | 19.08M | Sep 29, 2024 |
| William Blair Investment Management, LLC | 3.84% | 2,392,061 | 16.65M | Sep 29, 2024 |
| Deutsche Bank Aktiengesellschaft | 3.30% | 2,056,816 | 14.32M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.34% | 1,458,503 | 10.15M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.00% | 1,245,472 | 8.67M | Oct 30, 2024 |
| Blair (William) Mutual Funds, Inc.-Small Cap Growth Fund | 1.35% | 842,614 | 5.86M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.08% | 674,760 | 4.70M | Sep 29, 2024 |
| Buffalo Small Cap Fund | 0.85% | 526,918 | 3.67M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.81% | 501,705 | 3.49M | Aug 30, 2024 |